Status:
RECRUITING
What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
IVF
Infertility
Eligibility:
All Genders
18+ years
Brief Summary
Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.
Detailed Description
Usually around 2/3 of IVF material will be discarded at the end of each treatment cycle, including immature oocytes, abnormal fertilized zygotes, poor grading embryos, spent culture medium, etc. Next ...
Eligibility Criteria
Inclusion
- Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment.
- Participant able to give voluntary, written, informed consent to participate in the study.
Exclusion
- Patient using donor gamete in IVF treatment
- Patient refuses to join and failed to giving consent for any reasons
Key Trial Info
Start Date :
July 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06021340
Start Date
July 4 2023
End Date
June 1 2027
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong and Prince of Wales Hospital
Hong Kong, Hong Kong